HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rieckmann, K. H. Articles by Carson, P. E. Search for Related Content PubMed PubMed Citation Articles by Rieckmann, K. H. Articles by Carson, P. E.

Effects of Tetracycline against Chloroquine-Resistant and Chloroquine-Sensitive Plasmodium Falciparum^*

Tetracycline was administered to 22 volunteers infected with chloroquine-resistant Plasmodium falciparum (either the Camp. or Marks strain) and to seven volunteers infected with chloroquine-sensitive P. falciparum (Uganda I strain). Volunteers had become partially immune to their infections before they received 250 mg of tetracycline hydrochloride, given orally every 6 hours for 3, 5, or 7 days. Clearance of asexual parasites, although slow (mean, 4.5 days), was observed after each regimen of medication. In febrile patients, fever and symptoms usually subsided more slowly. After treatment with tetracycline for 3 days, initial clearance of patent parasitemia preceded recrudescence of asexual parasites in ll three patients infected with chloroquine-resistant malaria. Treatment for 5 days effected radical cure in all five infections with the Camp. strain, but parasitemia recurred in the single infection with the Ugandan strain. Administration of tetracycline for 7 days effected radical cure in all 10 persons infected with the Camp. strain, in 3 of 4 persons infected with the Marks strain, and in all 6 persons infected with the Uganda I strain. Tetracycline seemed to exert no effect against gametocytes. The findings indicate that tetracycline, although not recommended for treatment of acute episodes of malaria, may be of potential value, as an adjunctive agent, in achieving radical cure of drug-resistant infections of P. falciparum.

Accepted for publication May 19, 1971.

^* The investigations presented in this report were made possible through the cooperation of the inmates and administrative staff of the Illinois State Penitentiary, Stateville Branch, Joliet, Illinois.

These studies were supported by the United States Army Medical Research and Development Command Contract DA-49-193-MD-2413. This paper is contribution No. 926 from the Army Malaria Research Program.

This article has been cited by other articles:

				B. Pradines, A. Tall, F. Ramiandrasoa, A. Spiegel, C. Sokhna, T. Fusai, J. Mosnier, W. Daries, J. F. Trape, G. Kunesch, et al. In vitro activity of iron-binding compounds against Senegalese isolates of Plasmodium falciparum J. Antimicrob. Chemother., June 1, 2006; 57(6): 1093 - 1099. [Abstract] [Full Text] [PDF]